RTTNews | Jul 12, 2021 09:34AM EDT

09:33 Monday, July 12, 2021 (RTTNews.com) - Quidel Corp. (QDEL) said that it has received the CE Mark for its Savanna multiplex molecular analyzer and Savanna RVP4 Assay (Respiratory Viral Panel-4). The CE Mark allows the company to market and sell the Savanna system in Europe, as well as other countries that accept the CE Mark.

The company noted that new Savanna platform can analyze up to 12 pathogens or targets, plus controls, from a single assay run in less than 30 minutes. The Savanna system is a fully integrated, sample-to-result automated in-vitro diagnostic platform that performs real-time Polymerization Chain Reaction (PCR) tests by using the Savanna instrument and Savanna assay cartridges.

The instrument performs sample and reagent preparation, nucleic acid extraction and amplification, real-time detection of RNA or DNA target sequence, and qualitative or quantitative result interpretation from a variety of sample types. The Savanna system is intended to aid in the diagnosis of the related diseases.

Quidel's initial Savanna RVP4 Assay (Respiratory Viral Panel-4) is a nucleic acid test intended for use with the Savanna instrument for the simultaneous qualitative detection and differentiation of influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV), and SARS-CoV-2 RNA isolated from human nasal or nasopharyngeal swabs in media obtained from patients with signs and symptoms of respiratory tract infection.

Read the original article on RTTNews ( https://www.rttnews.com/3208401/quidel-obtains-ce-mark-for-savanna-multiplex-molecular-analyzer-respiratory-viral-panel.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved